News Image

Which stocks are moving after the closing bell on Tuesday?

By Mill Chart

Last update: Apr 23, 2024

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

After hours gainers

TickerChangeComment
CSSE56.2%After the regular session, CHICKEN SOUP FOR THE SOUL EN (NASDAQ:CSSE) continues to impress in the after-hours session, with a 56.2% increase to $0.24. The stock is trading 56.71% lower than 6 months ago.
CLEU12.15%CHINA LIBERAL EDUCATION HOLD's (NASDAQ:CLEU) stock price is advancing with 12.15% to a price of $1.2. In the last 3 months the share price dropped with 58.2%.
CDTX10.93%After the regular session, CIDARA THERAPEUTICS INC (NASDAQ:CDTX) continues to impress in the after-hours session, with a 10.93% increase to $0.57. Shareholders saw the stock price going 31.34% lower in the past month.
TSLA7.34%Impressive after-hours gains for TESLA INC (NASDAQ:TSLA) as its stock price advanced 7.34% to $155.3 during Tuesday's after-hours session. TESLA INC released earnings Yesterday. Yesterday the company had a press release: Tesla Stock Analysis: Insights and Future Projections.
WFRD6.7%WEATHERFORD INTERNATIONAL PL's (NASDAQ:WFRD) shares rose 6.7% to $126.0 during Tuesday's after hours session. WEATHERFORD INTERNATIONAL PL released earnings Yesterday. The stock is trading 26.45% higher than 6 months ago.
BQ6.32%In the after-hours session on Tuesday, BOQII HOLDING LTD (NYSEARCA:BQ) experienced a notable 6.32% increase, driving its shares to $0.27. Shareholders saw the stock price going 31.23% lower in the past 3 months.
VLCN6.01%VOLCON INC's (NASDAQ:VLCN) stock price increased by 6.01% to $0.31. The positive market sentiment seen in today's regular session, where NASDAQ:VLCN closed with a 26.38% gain, carries over into the after-hours session.
TXN5.39%TEXAS INSTRUMENTS INC's (NASDAQ:TXN) shares rose 5.39% to $174.39. TEXAS INSTRUMENTS INC released earnings Yesterday.
ABVC5.19%Positive after-hours movement for ABVC BIOPHARMA INC (NASDAQ:ABVC) as its shares recorded a 5.19% increase, reaching $1.42 during Tuesday's after-hours session. This is a continuation of today's gain of 29.81%.
ADVM5.0%Notable gains for ADVERUM BIOTECHNOLOGIES INC (NASDAQ:ADVM) in the after-hours session, with a 5.0% rise to $11.55 during Tuesday. Shareholders saw the stock price going 26.42% lower in the past month.

To see the full list of after hours gainers you can use our after hours gainers page.

Today's after hours losers

TickerChangeComment
FRES-17.23%Today's after-hours session sees a continuation of the 20.82% decrease earlier in the day for NASDAQ:FRES. Price movements remain volatile as NASDAQ:FRES gives back 20.82% of its earlier gains in the after-hours session. A press release (Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq) was released two days ago.
KPRX-13.79%Following a 19.59% loss in the regular session, NASDAQ:KPRX exhibits further decline during today's after-hours session. Despite a strong 19.59% gain earlier today, NASDAQ:KPRX is experiencing a reversal in after-hours trading, with prices declining by 13.79%.
CLDI-10.24%After today's %ABSPERF% drop, NYSEARCA:CLDI shows further decline during today's after-hours session with a 10.24% decrease. Yesterday the company had a press release: Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on April 24.
EQX-8.04%Price volatility persists as NYSEARCA:EQX closed the regular session with a %ABSPERF% loss, and the downward trend continues in the after-hours session. A press release (Equinox Gold Consolidates Ownership of the Greenstone Gold Mine, Arranges Term Loan and Bought Deal Equity Financing) was released earlier today.
TLSA-7.95%TIZIANA LIFE SCIENCES LTD's (NASDAQ:TLSA) shares experienced a 7.95% decrease to $0.71 in the after-hours session. yesterday the company released their earnings. A press release (Tiziana Life Sciences Announces FDA Allowance for Additional Twenty Patients to be Enrolled in the Intranasal Foralumab Multiple Sclerosis Expanded Access Program) was released yesterday.
NUWE-6.67%NUWELLIS INC's (NASDAQ:NUWE) shares fell 6.67% to $0.28 during Tuesday's after hours session. It appears that the downward trend persists as NASDAQ:NUWE also experienced a -10.18% decline during the regular session.
ASLN-6.38%ASLAN PHARMACEUTICALS LT-ADR's (NASDAQ:ASLN) stock price saw a decrease of 6.38% to $0.44 during Tuesday's after-hours session. Two days ago the company had a press release: ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients.
SING-5.91%Price volatility persists as NYSEARCA:SING closed the regular session with a 18.16% loss, and the downward trend continues in the after-hours session. After registering a 18.16% gain earlier today, NYSEARCA:SING is experiencing a 5.91% decline in today's after-hours session.
AULT-5.68%Today's after-hours session sees a continuation of the %ABSPERF% decrease earlier in the day for NYSEARCA:AULT. Shareholders saw the stock price going 50.52% lower in the past 3 months.
SNGX-5.0%SOLIGENIX INC's (NASDAQ:SNGX) shares experienced a 5.0% decrease to $0.38 in the after-hours session. The stock is trading 35.48% lower than a month ago.

To see the full list of after hours losers you can use our after hours losers page.

Back

SOLIGENIX INC

NASDAQ:SNGX (5/17/2024, 8:28:34 PM)

After market: 0.385 -0.01 (-1.94%)

0.3926

+0 (+0.67%)

SNGX News

News Image3 days ago - Soligenix, Inc.Positive Clinical Results from HyBryte™ Compatibility Study in the Treatment of Cutaneous T-Cell Lymphoma Published in JEADV Clinical Practice

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

News Image6 days ago - BusinessInsiderSNGX Stock Earnings: Soligenix Beats EPS, Misses Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Soligenix (NASDAQ:SNGX) just reported results for the first quarter of 2024.Sol...

News Image6 days ago - InvestorPlaceSNGX Stock Earnings: Soligenix Beats EPS, Misses Revenue for Q1 2024

SNGX stock results show that Soligenix beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

News Image9 days ago - ChartmillWhich stocks are moving after the closing bell on Friday?

What's going on in today's after hours session

News Image9 days ago - Soligenix, Inc.Soligenix Announces Recent Accomplishments And First Quarter 2024 Financial Results

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

News Image13 days ago - Soligenix, Inc.Soligenix to Present at Upcoming Conferences

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

News Image24 days ago - Soligenix, Inc.Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and South Africa

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing...

News Imagea month ago - Soligenix, Inc.Soligenix Announces Pricing of $4.75 Million Public Offering

/PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) ("Soligenix" or the "Company"), a late-stage biopharmaceutical company focused on developing and commercializing...

News Imagea month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!

News Imagea month ago - Yahoo FinanceWhy Is Penny Stock Soligenix Trading Higher On Monday?

On Monday, Soligenix Inc (NASDAQ:SNGX) received an FDA orphan drug designation for the active ingredient in MarVax, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for the prevention and post-exposure prophylaxis against MARV infection. In addition to providing a seven-year term of market exclusivity upon final FDA approval, orphan drug designation also positions Soligenix to be able to leverage a wide range of financial and regulatory benefits, i

News Imagea month ago - InvestorPlaceWhy Are Stocks Up Today?

Stocks are up today and investors wondering what's behind that rally have come to the right place as we have the latest news for Monday!

SNGX Links
Follow us for more